A growing body of evidence shows that obesity can drive the progression of CKD and that the pathophysiological mechanisms are multifaceted, including altered hemodynamics, systemic inflammation, oxidative stress, and activation of the renin-angiotensin-aldosterone system (RAAS). Here, REN is linked to obesity due to melanocortin 4 receptor deficiency.